• bitcoinBitcoin(BTC)$79,896.00-1.17%
  • ethereumEthereum(ETH)$2,311.63-2.29%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$740.24-0.88%
  • rippleXRP(XRP)$1.28-2.07%
  • usd-coinUSDC(USDC)$1.000.01%
  • solanaSolana(SOL)$100.89-1.60%
  • tronTRON(TRX)$0.3299890.33%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.06-0.69%
  • zcashZcash(ZEC)$1,195.17-1.79%
  • HyperliquidHyperliquid(HYPE)$75.63-1.49%
  • dogecoinDogecoin(DOGE)$0.076728-1.44%
  • moneroMonero(XMR)$590.16-3.18%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$76.91-1.35%
  • chainlinkChainlink(LINK)$11.37-1.79%
  • leo-tokenLEO Token(LEO)$9.01-0.32%
  • cardanoCardano(ADA)$0.203053-2.36%
  • RainRain(RAIN)$0.0083381.60%
  • stellarStellar(XLM)$0.168017-2.14%
  • nearNEAR Protocol(NEAR)$4.48-0.21%
  • bitcoin-cashBitcoin Cash(BCH)$279.140.67%
  • Ethena USDeEthena USDe(USDE)$1.000.00%
  • daiDai(DAI)$1.00-0.02%
  • litecoinLitecoin(LTC)$56.44-1.05%
  • uniswapUniswap(UNI)$6.860.50%
  • CantonCanton(CC)$0.1010220.02%
  • USD1USD1(USD1)$1.00-0.01%
  • avalanche-2Avalanche(AVAX)$8.85-1.28%
  • suiSui(SUI)$0.91-2.47%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.24-1.04%
  • hedera-hashgraphHedera(HBAR)$0.076802-1.56%
  • tether-goldTether Gold(XAUT)$4,009.740.41%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • shiba-inuShiba Inu(SHIB)$0.000005-1.83%
  • BittensorBittensor(TAO)$249.80-0.85%
  • quant-networkQuant(QNT)$190.733.57%
  • EthenaEthena(ENA)$0.2042974.46%
  • crypto-com-chainCronos(CRO)$0.053693-2.80%
  • BitwayBitway(BTW)$1.64-4.68%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.07%
  • okbOKB(OKB)$107.48-0.76%
  • MemeCoreMemeCore(M)$0.977.47%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$134.53-2.30%
  • OndoOndo(ONDO)$0.404848-1.15%
  • Pump.funPump.fun(PUMP)$0.004168-3.32%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Elon Musk microdoses ketamine to treat depression: report

June 27, 2023
in Business
Reading Time: 7 mins read
A A
Elon Musk microdoses ketamine to treat depression: report
ShareShareShareShareShare

Elon Musk uses small doses of ketamine to treat depression and occasionally takes full doses of the popular club drug known as Special K when he attends parties, according to a report.

Musk’s alleged use of ketamine — a tranquilizer that has hallucinogenic qualities and is usually prescribed by veterinarians — is part of a growing trend by Silicon Valley executives who have engaged in recreational use of psychedelics for alleged benefits in boosting business performance and creativity, the Wall Street Journal reported on Tuesday.

YOU MAY ALSO LIKE

Skechers’s beachside SoCal HQ goes on the market after massive renovation

What is Ciao Hospitality Group?

According to the publication, the Tesla, Twitter and Space X boss has told people he microdoses ketamine for depression, and he also takes full doses of Special K at parties, according to people who have witnessed his drug use and others who have direct knowledge of it.

The Post reached out to Musk for comment.

After The Journal story was published, Musk took to his social media platform to tout the benefits of ketamine, which has gained popularity as an alternative treatment for depression.

“Depression is overdiagnosed in the US, but for some people it really is a brain chemistry issue,” Musk tweeted.

“But zombifying people with SSRIs for sure happens way too much,” he added, referring to more common anti-depressants.

Musk, who famously smoked marijuana during an appearance on Joe Rogan’s podcast, added: “From what I’ve seen with friends, ketamine taken occasionally is a better option.”

The purported benefits of ketamine have also attracted the attention of Wall Street executives, who reportedly pay $750 at a swanky Manhattan clinic that injects them with the drug.


Tesla mogul Elon Musk reportedly uses ketamine to treat depression.
REUTERS

The billionaire wasn’t the only tycoon to allegedly dabble in hallucinogenic drugs.

Musk’s good friend, Google co-founder Sergey Brin, has dropped magic mushrooms, The Journal reported.

Brin was not immediately available for comment.

The ‘shrooms, which contain the hallucination-inducing chemical psilocybin, and LSD have been shown in clinical trials to have benefits in treating depression and other mental health maladies.

The Journal reported on a vast underground of tech-centric parties and social gatherings where executives employ chemists and even buy ecstasy and other hallucinogens from drug dealers.

Depression is overdiagnosed in the US, but for some people it really is a brain chemistry issue.

But zombifying people with SSRIs for sure happens way too much. From what I’ve seen with friends, ketamine taken occasionally is a better option.

— Elon Musk (@elonmusk) June 27, 2023

Founders Fund, the high-powered San Francisco-based venture capital firm co-founded by Peter Thiel, is reported to have thrown exclusive parties that involved psychedelic drug use, according to The Journal.

A spokesperson for Founders Fund told The Journal: “Research shows that psychedelics can provide significant mental health benefits, and we support public and private sector efforts to make these drugs safely and legally available.”

Spencer Shulem, the New York City-based CEO of the startup firm BuildBetter.ai, credits use of LSD with helping him concentrate and think creatively.

Shulem, who said he takes LSD once every three months, told The Journal that psychedelics give him a leg up against other techies who are vying for venture capital cash.

“They don’t want a normal person, a normal company,” he said of VC firms.


Elon Musk's friend, Google co-founder Sergey Brin, reportedly uses magic mushrooms.
Elon Musk’s friend and Google co-founder, Sergey Brin, reportedly uses magic mushrooms — which have been shown in clinical trials to have benefits in treating depression and other mental health maladies.
Getty Images for Breakthrough Prize

“They want something extraordinary. You’re not born extraordinary.”

Nonetheless, Shulem said he does not actively encourage his workers to take LSD.

 “I am not having a preaching seminar every Friday about the joys of drugs,” he said.


Credit: Source link

ShareTweetSendSharePin

Related Posts

Skechers’s beachside SoCal HQ goes on the market after massive renovation
Business

Skechers’s beachside SoCal HQ goes on the market after massive renovation

October 25, 2026
What is Ciao Hospitality Group?
Business

What is Ciao Hospitality Group?

October 25, 2026
Halloween candy sales off to slow start amid high chocolate prices, affordability concerns
Business

Halloween candy sales off to slow start amid high chocolate prices, affordability concerns

October 25, 2026
New images released of Anagram apartment tower along NYC’s Gowanus Canal
Business

New images released of Anagram apartment tower along NYC’s Gowanus Canal

October 25, 2026
Next Post
Butlers Aren’t Just for Downtown Abbey, Get one From Hello Alfred

Butlers Aren't Just for Downtown Abbey, Get one From Hello Alfred

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Block Unveils Dessa, a Full-Duplex Speech Model Trained on Conversation – Unite.AI

Block Unveils Dessa, a Full-Duplex Speech Model Trained on Conversation – Unite.AI

October 23, 2026
Daft Punk Is Getting An Official Lego Set

Daft Punk Is Getting An Official Lego Set

October 22, 2026
What Is Data Poisoning? How Attackers Corrupt AI Models and Datasets – Unite.AI

What Is Data Poisoning? How Attackers Corrupt AI Models and Datasets – Unite.AI

October 25, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!